Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F8N5C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,859
Award facts
- Contract value 100% obligated
- $12,859.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,859.19 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. The contract, which was competitively awarded without a set-aside designation, is scheduled for completion by January 8, 2026, just one day after the award date of January 7, 2026. The firm fixed-price delivery order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement supporting federal medical supply needs.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of medications, medical supplies, specialty drugs, and vaccines to support military healthcare programs worldwide. AmerisourceBergen's established role as a critical pharmaceutical vendor for the Defense Logistics Agency and other federal health systems reflects the company's capability to efficiently fulfill government requirements for essential pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F8N5C?
SPE2DR26F8N5C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F8N5C worth?
The government has obligated $12,859 on SPE2DR26F8N5C.
Is contract SPE2DR26F8N5C an order under another contract?
Yes. SPE2DR26F8N5C is a delivery order under SPE2DR25D3022, an indefinite delivery contract.
Was contract SPE2DR26F8N5C competed?
The extent of competition for SPE2DR26F8N5C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award